We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.
This guidance relates to Standard Essential Patents licensing.
Product defect recall alert for Folltropin 700 IU Powder and Solvent for Solution for Injection by Vetoquinol SA and Vetoquinol UK Limited.
This guidance describes the dispute resolution services and remedies available for standard essential patents (SEPs) disputes.
Accord Healthcare limited is recalling a single batch due to an out of specification test result.
Information about opinions requests we have received this year.
Development of a standard approach for AI and autonomy in networked multi-sensor systems in security and defence.
This section of the SEPs Resource Hub signposts to international SEPs-specific information, including for the purposes of patent applications.
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
Buying Solutions is now a part of the Government Procurement Service.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).